Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

On its third-quarter earnings call, Glaukos emphasized the growing use of iStent infinite for glaucoma patients, especially those who have not responded to other treatments. This growth is driven ...

It offers iStent, a micro-bypass stent for insertion in conjunction with cataract surgery for the reduction of intraocular pressure in adult patients with mild-to-moderate open-angle glaucoma.

Unfortunately, visual loss caused by glaucoma is irreversible. Current treatments include topical and/or oral medications, laser surgery or conventional surgery. The iStent Trabecular Micro-Bypass ...

Fairless Focus Business Profiles, Focus on Health, Langhorne Ledger Business Profiles, Newtown Gazette Business Profiles, ...

Additionally, high demand for Glaukos' international glaucoma and Corneal Health products continues to fuel investor optimism. During its third-quarter earnings call, Glaukos highlighted the ...